Table 2.
CDK1 expression in PCa samples and noncancer samples based on mRNA-array and mRNA-sequencing data.
| Study | Country | Year | Sample type | PCa | Non-PCa | ||||
|---|---|---|---|---|---|---|---|---|---|
| N | M | SD | N | M | SD | ||||
| GSE6919 | USA | 2007 | Tissue | 90 | 4.854 | 0.889 | 81 | 4.096 | 0.845 |
| GSE104749 | China | 2017 | Tissue | 4 | 8.876 | 0.846 | 4 | 5.389 | 0.539 |
| GSE73397 | China | 2015 | Tissue | 3 | 9.600 | 0.086 | 3 | 9.393 | 0.097 |
| GSE69223 | Germany | 2015 | Tissue | 15 | 0.141 | 0.994 | 15 | −0.250 | 0.761 |
| GSE94767 | UK | 2017 | Tissue | 185 | 4.376 | 0.697 | 33 | 3.937 | 0.366 |
| GSE60329 | Italy | 2014 | Tissue | 108 | −0.063 | 1.089 | 28 | −0.046 | 0.571 |
| GSE72220 | USA | 2015 | Tissue | 57 | −0.101 | 0.090 | 90 | −0.127 | 0.106 |
| GSE46602 | Denmark | 2013 | Tissue | 34 | 2.767 | 0.418 | 14 | 2.534 | 0.247 |
| GSE38043 | USA | 2012 | Body fluid | 3 | 6.000 | 0.124 | 3 | 6.655 | 0.754 |
| GSE32982 | Finland | 2011 | Tissue | 6 | 5.582 | 0.447 | 3 | 5.473 | 0.119 |
| GSE35988 | USA | 2012 | Tissue | 76 | 1.829 | 1.676 | 12 | 0.008 | 0.584 |
| GSE28204 | China | 2011 | Tissue | 4 | 8.031 | 6.381 | 4 | 6.381 | 0.762 |
| GSE32448 | USA | 2011 | Tissue | 40 | 5.861 | 0.756 | 40 | 5.740 | 0.811 |
| GSE26910 | Italy | 2011 | Tissue | 6 | 3.354 | 0.323 | 6 | 3.279 | 0.181 |
| GSE12378 | UK | 2008 | Tissue | 36 | 4.128 | 0.494 | 3 | 3.973 | 0.427 |
| TCGA+GTEx | NA | NA | Tissue | 492 | 1.461 | 0.754 | 152 | 1.048 | 0.570 |
CDK1: cyclin-dependent kinase 1; GTEx: The Genotype-Tissue Expression; M: mean; N: number; PCa: prostate cancer; SD: standard deviation; TCGA: The Cancer Genome Atlas.